LFS-31

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameLFS-31
Drug Alias NameLFS-31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExportin-1 protein inhibitors
TargetsExportin-1 protein
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDalian University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesDalian University Of Technology
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A